These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 5783593

  • 1. Irreversible enzyme inhibitors. 148. Active-site-directed irreversible inhibitors of guanine deaminase derived from 9-phenylguanine bearing a terminal sulfonyl fluoride.
    Baker BR, Wood WF.
    J Med Chem; 1969 Mar; 12(2):216-20. PubMed ID: 5783593
    [No Abstract] [Full Text] [Related]

  • 2. Irreversible enzyme inhibitors. 185. Active-site-directed irreversible inhibitors of guanine deaminase derived from 9-phenylguanine bearing a terminal sulfonyl fluoride. 2.
    Baker BR, Siebenneick HU.
    J Med Chem; 1971 Sep; 14(9):802-5. PubMed ID: 5168672
    [No Abstract] [Full Text] [Related]

  • 3. Irreversible enzyme inhibitors. 178. Active-site-directed irreversible inhibitors of dihydrofolate reductase derived from 1-(4-benzyloxy-3-chlorophenyl)-4,6-diamino-1,2-dihydro-2,2-dimethyl-s-triazine with a terminal sulfonyl fluoride.
    Baker BR, Ashton WT.
    J Med Chem; 1970 Nov; 13(6):1161-5. PubMed ID: 5479857
    [No Abstract] [Full Text] [Related]

  • 4. Irreversible enzyme inhibitors. CLXXIX. Active-site-directed irreversible enzyme inhibitors of dihydrofolate reductase from 1-(3-chlorophenyl)-4,6-diamino-1,2-dihydro-2,2-dimethyl-s-triazine with oxyamide bridges to a terminal sulfonyl fluoride.
    Baker BR, Ashton WT.
    J Med Chem; 1970 Nov; 13(6):1165-70. PubMed ID: 5479858
    [No Abstract] [Full Text] [Related]

  • 5. Irreversible enzyme inhibitors. CII. On the mode of phenyl binding of 9-phenylguanine to guanine deaminase and xanthine oxidase.
    Baker BR, Wood WF.
    J Med Chem; 1967 Nov; 10(6):1101-5. PubMed ID: 6056037
    [No Abstract] [Full Text] [Related]

  • 6. Irreversible enzyme inhibitors. CXLVI. Active-site-directed irreversible inhibitors of xanthine oxidase derived from 9-(acylamidophenyl)guanines substituted with a terminal sulfonyl fluoride.
    Baker BR, Wood WF.
    J Med Chem; 1969 Mar; 12(2):211-4. PubMed ID: 5783591
    [No Abstract] [Full Text] [Related]

  • 7. Irreversible enzyme inhibitors. CXIX. Active-site-directed irreversible inhibitors of dihydrofolic reductase with tissue specificity derived from 2,4,6-triaminopyrimidine with a terminal sulfonyl fluoride at the 5 position.
    Baker BR, Meyer RB.
    J Med Chem; 1968 May; 11(3):489-94. PubMed ID: 5241408
    [No Abstract] [Full Text] [Related]

  • 8. Correlation analysis of Baker's studies on enzyme inhibition. 1. Guanine deaminase, xanthine oxidase, dihydrofolate reductase, and complement.
    Silipo C, Hansch C.
    J Med Chem; 1976 Jan; 19(1):62-71. PubMed ID: 1246055
    [Abstract] [Full Text] [Related]

  • 9. Irrevesible enzyme inhibitors. CLI. Active-site-directed irreversible inhibitors of dihydrofolic reductase derived from 5-(p-aminophenylbutyl)-2,4-diaminopyrimidines with a terminal sulfonyl fluoride.
    Baker BR, Meyer RB.
    J Med Chem; 1969 Mar; 12(2):224-7. PubMed ID: 5254099
    [No Abstract] [Full Text] [Related]

  • 10. Irreversible enzyme inhibitors. CLXXVI. Active-site-directed irreversible inhibitors of dihydrofolate reductase derived from 4,6-diamino-1,2-dihydro-2,2-dimethyl-1-phenyl-s-triazine by ether bridging to a terminal sulfonyl fluoride.
    Baker BR, Ashton WT.
    J Med Chem; 1970 Nov; 13(6):1149-54. PubMed ID: 5479855
    [No Abstract] [Full Text] [Related]

  • 11. Irreversible enzyme inhibitors. CXII. Active-site-directed irreversible inhibitors of dihydrofolic reductase derived from 4,6-diamino-1,2-dihydro-2,2-dimethyl-1-phenyl-s-triazine substituted with a terminal sulfonyl fluoride. II.
    Baker BR, Lourens GJ.
    J Med Chem; 1968 Jan; 11(1):38-41. PubMed ID: 5237173
    [No Abstract] [Full Text] [Related]

  • 12. Irreversible enzyme inhibitors. CXXV. Active-site-directed irreversible inhibitors of xanthine oxidase derived from arylpurines and pyrazolo[3,4-d]pyrimidines bearing a terminal sulfonyl fluoride.
    Baker BR, Kozma JA.
    J Med Chem; 1968 Jul; 11(4):656-61. PubMed ID: 5671223
    [No Abstract] [Full Text] [Related]

  • 13. Irreversible enzyme inhibitors. 202. Candidate active-site-directed irreversible inhibitors of 5-fluoro-2'-deoxyuridine phosphorylase from Walker 256 rat tumor derived from 1-benzyl-5-(3-ethoxybenzyl)uracil.
    Kelley JL, Baker BR.
    J Med Chem; 1982 May; 25(5):600-3. PubMed ID: 6211547
    [Abstract] [Full Text] [Related]

  • 14. Irreversible enzyme inhibitors. CXXXIX. p-(4,6-Diamino-1,2-dihydro-2,2-dimethyl-s-triazin-1-yl)phenylpropionylsulfanilyl fluoride, an active-site-directed irreversible inhibitor of dihydrofolic reductase. VI. Further studies on effects of substitution on the propionamide bridge on isozyme specificity.
    Baker BR, Lourens GJ.
    J Med Chem; 1969 Jan; 12(1):92-4. PubMed ID: 5763049
    [No Abstract] [Full Text] [Related]

  • 15. Irreversible enzyme inhibitors. CXLVII. Candidate active-site-directed irreversible inhibitors of xanthine oxidase derived from 9-(p-acylamidoalkoxyphenyl)guanines bearing a terminal sulfonyl fluoride.
    Baker BR, Wood WF.
    J Med Chem; 1969 Mar; 12(2):214-6. PubMed ID: 5783592
    [No Abstract] [Full Text] [Related]

  • 16. Irreversible enzyme inhibitors. CXLII. Further studies on active-site-directed irreversible inhibitors of dihydrofolic reductase derived from 5-(p-Aminophenoxypropyl)-2,4,6-triaminopyrimidine bearing a terminal sulfonyl fluoride.
    Baker BR, Meyer RB.
    J Med Chem; 1969 Jan; 12(1):104-7. PubMed ID: 5763003
    [No Abstract] [Full Text] [Related]

  • 17. Irreversible enzyme inhibitors. CXXXVII. Active-site-directed irreversible inhibitors of dihydrofolic reductase derived from 6-(p-aminomethylphenoxymethyl)-2,4-diamino-5-(3,4-dichlorophenyl)pyrimidine bearing a terminal sulfonyl fluoride.
    Baker BR, Vermeulen NM.
    J Med Chem; 1969 Jan; 12(1):86-8. PubMed ID: 5763047
    [No Abstract] [Full Text] [Related]

  • 18. Enzyme inhibitors. XX. Studies on the hydrophobic and hydroxyl binding regions of adenosine deaminase. 9-(2-m-Bromoacetamidophenethyl)adenine, a new irreversible inhibitor of adenosine deaminase.
    Schaeffer HJ, Johnson RN.
    J Med Chem; 1968 Jan; 11(1):21-6. PubMed ID: 5637186
    [No Abstract] [Full Text] [Related]

  • 19. Irreversible enzyme inhibitors. CLXXV. Irreversible inhibition of purified dihydrofolic reductase.
    Baker BR, Vermeulen NM.
    J Med Chem; 1970 Nov; 13(6):1143-8. PubMed ID: 5479854
    [No Abstract] [Full Text] [Related]

  • 20. Irreversible enzyme inhibitors. 143. Active-site-directed irreversible inhibitors of dihydrofolic reductase derived from 5-(p-aminophenoxypropyl)-2,4-diamino-6-methylpyrimidine with a terminal sulfonyl fluoride.
    Baker BR, Meyer RB.
    J Med Chem; 1969 Jan; 12(1):108-11. PubMed ID: 5763004
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.